These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 36515455)

  • 1. Membrane-coated nanoparticles for direct recognition by T cells.
    Li F; Li F; Urie R; Bealer E; Ruiz RO; Saito E; Turan A; Yolcu E; Shirwan H; Shea LD
    Biotechnol Bioeng; 2023 Mar; 120(3):767-777. PubMed ID: 36515455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pro-inflammatory chitosan/poly(γ-glutamic acid) nanoparticles modulate human antigen-presenting cells phenotype and revert their pro-invasive capacity.
    Castro F; Pinto ML; Silva AM; Pereira CL; Teixeira GQ; Gomez-Lazaro M; Santos SG; Barbosa MA; Gonçalves RM; Oliveira MJ
    Acta Biomater; 2017 Nov; 63():96-109. PubMed ID: 28919508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of the antigen presenting cell in rat autoimmune myocarditis: evidence of bone marrow derivation and non-requirement for MHC class I compatibility with pathogenic T cells.
    Ratcliffe NR; Wegmann KW; Zhao RW; Hickey WF
    J Autoimmun; 2000 Nov; 15(3):369-79. PubMed ID: 11040077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adhesive substrates modulate the activation and stimulatory capacity of non-obese diabetic mouse-derived dendritic cells.
    Acharya AP; Dolgova NV; Xia CQ; Clare-Salzler MJ; Keselowsky BG
    Acta Biomater; 2011 Jan; 7(1):180-92. PubMed ID: 20807596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles.
    Shen H; Ackerman AL; Cody V; Giodini A; Hinson ER; Cresswell P; Edelson RL; Saltzman WM; Hanlon DJ
    Immunology; 2006 Jan; 117(1):78-88. PubMed ID: 16423043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human sunlight-induced basal-cell-carcinoma-associated dendritic cells are deficient in T cell co-stimulatory molecules and are impaired as antigen-presenting cells.
    Nestle FO; Burg G; Fäh J; Wrone-Smith T; Nickoloff BJ
    Am J Pathol; 1997 Feb; 150(2):641-51. PubMed ID: 9033277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
    Bodey B; Bodey B; Kaiser HE
    In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomimetic Nanoparticles Enabled by Cascade Cell Membrane Coating for Direct Cross-Priming of T Cells.
    Chen F; Geng Z; Wang L; Zhou Y; Liu J
    Small; 2022 Jan; 18(3):e2104402. PubMed ID: 34837321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptor 3-induced immune response by poly(d,l-lactide-co-glycolide) nanoparticles for dendritic cell-based cancer immunotherapy.
    Han HD; Byeon Y; Kang TH; Jung ID; Lee JW; Shin BC; Lee YJ; Sood AK; Park YM
    Int J Nanomedicine; 2016; 11():5729-5742. PubMed ID: 27843314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of biodegradable nanoparticles to modulate phenotypes of antigen-presenting cells for antigen-specific treatment of autoimmune disease.
    Saito E; Kuo R; Kramer KR; Gohel N; Giles DA; Moore BB; Miller SD; Shea LD
    Biomaterials; 2019 Nov; 222():119432. PubMed ID: 31480002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
    da Cunha A; Antoniazi Michelin M; Cândido Murta EF
    Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational design of nanoparticles towards targeting antigen-presenting cells and improved T cell priming.
    Zupančič E; Curato C; Paisana M; Rodrigues C; Porat Z; Viana AS; Afonso CAM; Pinto J; Gaspar R; Moreira JN; Satchi-Fainaro R; Jung S; Florindo HF
    J Control Release; 2017 Jul; 258():182-195. PubMed ID: 28511928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered Cell-Membrane-Coated Nanoparticles Directly Present Tumor Antigens to Promote Anticancer Immunity.
    Jiang Y; Krishnan N; Zhou J; Chekuri S; Wei X; Kroll AV; Yu CL; Duan Y; Gao W; Fang RH; Zhang L
    Adv Mater; 2020 Jul; 32(30):e2001808. PubMed ID: 32538494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection.
    Pêche H; Heslan M; Usal C; Amigorena S; Cuturi MC
    Transplantation; 2003 Nov; 76(10):1503-10. PubMed ID: 14657694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen delivery to dendritic cells by poly(propylene sulfide) nanoparticles with disulfide conjugated peptides: Cross-presentation and T cell activation.
    Hirosue S; Kourtis IC; van der Vlies AJ; Hubbell JA; Swartz MA
    Vaccine; 2010 Nov; 28(50):7897-906. PubMed ID: 20934457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting antigen-specific T cells by genetically engineered antigen presenting cells. A strategy for specific immunotherapy of autoimmune disease.
    Wu JM; Wu B; Guarnieri F; August JT; Drachman DB
    J Neuroimmunol; 2000 Jul; 106(1-2):145-53. PubMed ID: 10814792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artificial human antigen-presenting cells are superior to dendritic cells at inducing cytotoxic T-cell responses.
    Li H; Shao S; Cai J; Burner D; Lu L; Chen Q; Minev B; Ma W
    Immunology; 2017 Nov; 152(3):462-471. PubMed ID: 28664991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Size-dependent accumulation of particles in lysosomes modulates dendritic cell function through impaired antigen degradation.
    Seydoux E; Rothen-Rutishauser B; Nita IM; Balog S; Gazdhar A; Stumbles PA; Petri-Fink A; Blank F; von Garnier C
    Int J Nanomedicine; 2014; 9():3885-902. PubMed ID: 25152619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PEGylation enables subcutaneously administered nanoparticles to induce antigen-specific immune tolerance.
    Li PY; Bearoff F; Zhu P; Fan Z; Zhu Y; Fan M; Cort L; Kambayashi T; Blankenhorn EP; Cheng H
    J Control Release; 2021 Mar; 331():164-175. PubMed ID: 33450320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lentiviral Protein Transfer Vectors Are an Efficient Vaccine Platform and Induce a Strong Antigen-Specific Cytotoxic T Cell Response.
    Uhlig KM; Schülke S; Scheuplein VA; Malczyk AH; Reusch J; Kugelmann S; Muth A; Koch V; Hutzler S; Bodmer BS; Schambach A; Buchholz CJ; Waibler Z; Scheurer S; Mühlebach MD
    J Virol; 2015 Sep; 89(17):9044-60. PubMed ID: 26085166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.